Logo image of DATS

DATCHAT INC (DATS) Stock Fundamental Analysis

NASDAQ:DATS - Nasdaq - US23816M2061 - Common Stock - Currency: USD

2.35  +0.09 (+3.98%)

After market: 2.33 -0.02 (-0.85%)

Fundamental Rating

2

DATS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. While DATS has a great health rating, there are worries on its profitability. DATS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DATS had negative earnings in the past year.
In the past year DATS has reported a negative cash flow from operations.
DATS had negative earnings in each of the past 5 years.
In the past 5 years DATS always reported negative operating cash flow.
DATS Yearly Net Income VS EBIT VS OCF VS FCFDATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

DATS has a Return On Assets of -98.56%. This is amonst the worse of the industry: DATS underperforms 88.42% of its industry peers.
DATS has a Return On Equity of -67.04%. This is in the lower half of the industry: DATS underperforms 72.63% of its industry peers.
Industry RankSector Rank
ROA -98.56%
ROE -67.04%
ROIC N/A
ROA(3y)-91.27%
ROA(5y)-651.68%
ROE(3y)-96.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DATS Yearly ROA, ROE, ROICDATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

DATS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DATS Yearly Profit, Operating, Gross MarginsDATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 -200K -400K -600K -800K -1M

More info and screens

7

2. Health

2.1 Basic Checks

DATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DATS has less shares outstanding
DATS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DATS Yearly Shares OutstandingDATS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
DATS Yearly Total Debt VS Total AssetsDATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -20.39, we must say that DATS is in the distress zone and has some risk of bankruptcy.
DATS has a worse Altman-Z score (-20.39) than 92.98% of its industry peers.
DATS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20.39
ROIC/WACCN/A
WACC10.9%
DATS Yearly LT Debt VS Equity VS FCFDATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 8.96 indicates that DATS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.96, DATS belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
A Quick Ratio of 8.96 indicates that DATS has no problem at all paying its short term obligations.
DATS has a better Quick ratio (8.96) than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 8.96
Quick Ratio 8.96
DATS Yearly Current Assets VS Current LiabilitesDATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.38% over the past year.
DATS shows a strong growth in Revenue. In the last year, the Revenue has grown by 150.00%.
EPS 1Y (TTM)63.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.67%
Revenue 1Y (TTM)150%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DATS Yearly Revenue VS EstimatesDATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 10K 20K 30K 40K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DATS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DATS Price Earnings VS Forward Price EarningsDATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DATS Per share dataDATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DATCHAT INC

NASDAQ:DATS (4/17/2025, 8:11:53 PM)

After market: 2.33 -0.02 (-0.85%)

2.35

+0.09 (+3.98%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners4.08%
Inst Owner Change0%
Ins Owners4.16%
Ins Owner Change0%
Market Cap10.06M
Analysts0
Price TargetN/A
Short Float %6.23%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20116
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-1.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS0
BVpS1.65
TBVpS1.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.56%
ROE -67.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.27%
ROA(5y)-651.68%
ROE(3y)-96.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.96
Quick Ratio 8.96
Altman-Z -20.39
F-Score4
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)150%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.17%
OCF growth 3YN/A
OCF growth 5YN/A